Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Research Collaboration with Vertex in Cystic Fibrosis : In July, Moderna announced an exclusive research collaboration and licensing agreement with Vertex Pharmaceuticals to discover and develop mRNA therapeutics for the treatment of cystic fibrosis (CF)
Do not rub the injection site as this can disperse the peptide away from the intended location
Gastrointestinal side effects are the most commonly reported and include: Nausea (affecting 1040% of patients, depending on the specific GLP-1 agonist) Vomiting and diarrhoea (less common than nausea but can contribute to dehydration) Constipation (due to slowed gastric emptying) Abdominal discomfort or bloating These effects are typically most pronounced during treatment initiation and following dose increases
Here is a quick breakdown before the details: All three are FDA-approved sites for subcutaneous semaglutide injection
And that came from a recent trial that was published in the New England Journal of Medicine
